We caught up with Ernest Choy (Cardiff University, Cardiff, UK) to discuss olokizumab as a novel rheumatoid arthritis (RA) treatment option. The symposia ‘Taking the High Road: Olokizumab as a Novel Rheumatoid Arthritis (RA) Treatment Option’ was presented at the virtual ACR Convergence 2020, 5-9 November 2020.
1.What is the rationale for the use of olokizumab in patients with rheumatoid arthritis?(0:12)
2.What clinical evidence supports the efficacy and safety of olokizumab in this indication?(0:38)
3.What are the advantages of olokizumab compared with other available IL-6 inhibitors?(1:28)
4.Which patients are most likely to benefit from olokizumab and in whom is it contraindicated?(1:56)
5.What will be the next steps in the clinical development of olokizumab in rheumatoid arthritis?(2:48)
Disclosures: Professor Choy has received speaker and consultancy fees from R-Pharm.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ACR 2020 Annual Meeting (Virtual).
Share this Video
Related Videos In Rheumatoid Arthritis
Anthony Sebba, ACR 2020 – Pain in Patients with Rheumatoid Arthritis (Part 1)
We were delighted to speak to Anthony Sebba (Arthritis Associates, FL, USA) to discuss whether pain and inflammation are independent of each other in patients with rheumatoid arthritis. The abstract ‘Pain and Other Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Who Did or Did Not Achieve Treatment Response Based on Improvement in Swollen Joints in […]
Peter C Taylor, ACR 2020 – Therapy Reduction in RA Patients in Remission: The SEAM-RA Trial (Part 1)
Following ACR Convergence 2020 we speak with Peter C Taylor (University of Oxford, Oxford, UK) about his highlights from the meeting. Part 1 in the series covers the SEAM-RA study designed to investigate the effect of therapy reduction in RA patients with persistent submission receiving a combination of methotrexate and etanercept. The abstract entitled ‘Maintenance […]
Anthony Sebba, ACR 2020 – Pain in Patients with Rheumatoid Arthritis (Part 3)
After his presentation at ACR 2020, we spoke with Anthony Sebba (Arthritis Associates, FL, USA) about the importance of studying pain as a patient reported outcome in rheumatoid arthritis and what further studies are needed. The abstract ‘Pain and Other Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Who Did or Did Not Achieve Treatment Response […]
Journal articles and more to your inbox
Get the latest clinical insights from touchIMMUNOLOGYSign me up!